DaVita Inc (LTS:0I7E)
$ 166.29 0 (0%) Market Cap: 13.59 Bil Enterprise Value: 24.69 Bil PE Ratio: 17.87 PB Ratio: 35.39 GF Score: 79/100

Q2 2024 DaVita Inc Earnings Call Transcript

Aug 06, 2024 / 09:00PM GMT
Release Date Price: $138.82 (+1.59%)
Editor

Please standby for live streaming.

Operator

I'd like to welcome on to the diabetes Second Quarter 2024 earnings call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer period. If you would like to ask a question during this time, simply press star and then the number one on your telephone keypad. If you would like to withdraw your question, press star and then the number two. Thank you. Mr. Eliassen, you may begin your call. Difference.

Nic Eliason
DaVita Inc - IR Contact Officer

Thank you and welcome to our second quarter conference call. We appreciate your continued interest in our company. I'm Nicholas and Group Vice President of Investor Relations. And joining me today are heavier Rodriguez, our CEO, and Joel Ackerman, our CFO. Please note that during this call, we may make forward-looking statements within the meaning of the federal securities laws.

All of these statements are subject to known and unknown risks and uncertainties

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot